TurboNuclease

TurboNuclease is an ultra-pure recombinant form of Serratia marcescens extracellular endonuclease (encoded by the same gene as Benzonase) produced in E. coli using a proprietary process. This non-specific endonuclease hydrolyzes both single- and double-stranded nucleic acids (DNA and RNA) to 5?-phosphorylated oligonucleotides of 1-4 bases in length. TurboNuclease is a highly purified homodimer of 27 kDa subunits that has exceptionally high specific activity and is free of protease activity. TurboNuclease is ideal to digest nucleic acids and to reduce viscosity during protein purification and sample preparation.

Sku# Product Name Product Size Price QTY

Sku#

1400010050

Product Name

TurboNuclease 50,000 Units

Product Size

50,000 Units

Price

$247.50 USD

QTY

Sku#

1400010100

Product Name

TurboNuclease 100,000 Units

Product Size

100,000 Units

Price

$473.00 USD

QTY

Sku#

1400010250

Product Name

TurboNuclease 250,000 Units

Product Size

250,000 Units

Price

$951.50 USD

QTY

Add to Cart

Protein Type:
Endonuclease

Source:
E. coli

Unit Definition:
One unit of TurboNuclease converts 1.0 OD260 of salmon sperm DNA into acid-soluble nucleotides in 30 minutes at 37oC in a reaction buffer of 50 mM Tris-HCl, pH 8.0 and 1 mM MgCl2. This corresponds to complete digestion of 50 µg of salmon sperm DNA into oligonucleotides. TurboNuclease has similar specific activity as Benzonase

Storage:
Store TurboNuclease at -20oC.

Endotoxin Level:
< 0.1 EU / 1,000 units of TurboNuclease as determined by the Endo-Safe LAL Assay.
Formulation: 250 units/µl in 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 5 mM MgCl2 and 50% Glycerol TurboNuclease Activity and Purity:
50 µg of salmon sperm DNA was incubated with the indicated units of TurboNuclease and another brand of nuclease at 37oC for 30 minutes in a buffer of 50 mM Tris-HCl, pH 8.0 and 1 mM MgCl2. DNA digestion was monitored by agarose gel.
TurboNuclease is purified through a proprietary process that achieves purity of >99%. TurboNuclease has no detectable protease activity.
TurboNuclease can be used to
reduce viscosity of cell lysate and reduce back pressure of column loading
remove nucleic acid contamination from sample preparations, reduce nucleic acid contamination of Ni column purification
reduce smearing in SDS-PAGE when used with 10%SDS or Gel Loading Dye to make whole cell lysate
reduce or prevent clumping of concentrated cells and thawed cells
replaces crude DNase I in many applications
To reduce viscosity of cell lysate, 10-500 units of TurboNuclease can be used for each gram of cell paste. Generally, adding TurboNuclease to cell lysate at 25 U/ml is sufficient to reduce lysate viscosity.
The efficiency of viscosity reduction may vary with buffers, cell types, and cell lysis methods used. Due to its high specific activity, the total amount TurboNuclease added is less than 0.1 ug/ml of lysate and will not complicate any down stream process.
Lare Scale Cell Lysis
  1. Make fresh cold Lysis Buffer
    Lysis Buffer should be a buffer in which the target protein is soluble.
    The Lysis Buffer should be compatible with downstream purification processes, e.g. minimal amount of EDTA or DTT if Ni column will be used.
Here is an example of Lysis Buffer
25 mM Tris-HCl, pH 8.0
500 mM NaCl
14 mM beta-mercaptoethanol
Detergent can be included for less soluble proteins or when protein solubility is unknown. 1% Triton X-100 has no effect on TurboNuclease activity.
TurboNuclease has the same activity in 150 mM NaCl or 500 mM NaCl and 400 mM imidazole.
  1. Resuspend thawed cell paste in Lysis Buffer
    Use 2-10 ml Lysis Buffer for each gram of cell paste. TurboNuclease can reduce the amount of Lysis Buffer used.
    We routinely use 2 ml of lysis buffer for each gram of cell pellets.
  2. Add TurboNuclease to 25 unit/ml
    Protease inhibitors can be added at the same time.
    If the lysis buffer contains EDTA or EGTA, add 10-fold more TurboNuclease.
  3. Lyze cells by mechanical or chemical methods on ice or at room temperature
    TurboNuclease also reduces the viscosity of lysate lyzed by microfluidizer.
  4. Clear lysate by centrifugation for column loading
    The reduced viscosity makes it possible to clear the lysate at lower speed. 35,000g (~16,000 rpm) for 1 hour is sufficient.
    Lysate can be loaded to "Crude" columns without clearance.
Parallel Lysis of Multiple Insect Cell Samples
  1. Freeze cells pellets of 5-10 ml culture on dry ice briefly
    Freeze and thaw facilitates lysis.
  2. Thaw the frozen pellets and completely resuspend in ~1 ml Lysis Buffer with TurboNuclease
  3. Transfer the cell suspension to a microtube and sit the tubes on a floater rack
  4. Lyze cells using an Ultrasonic Cleaner with ice waterbath for 10 min
    Ultrasonic Cleaner (many chemists use it) is much cheaper than probe sonicator. It costs a few hundreds US dollars for a new model and less than $100 for a used one or a jewelry cleaner from a consumer goods store. Ultrasonic Cleaner is much better and cheaper than those fancy multi-probe sonicators with the following advantages.
There is no cross-contamination since each sample is enclosed in a microtube.
The samples are always cold as long as ice is added in the water-bath.
There is no limit on the number of samples processed in parallel. A small Ultrasonic Cleaner can easily hold 48 samples
The lysate can be used for analyses of protein expression of whole cell lysate, soluble lysate, or affinity pull-down.
Eton Bio Lysis Buffer
25 mM Tris-HCl, pH 8.0
500 mM NaCl
20 mM Imidazole, pH 8.0
14 mM beta-mercaptoethanol
0.5% Triton X-100
25 units/ml TurboNuclease
Material Safety Data Sheet Date:Dec 4,2017 1. PRODUCT AND COMPANY IDENTIFICATION 1.1 Product identifier Product name: TurboNuclease Catalog No: 1400010050, 1400010100, 1400010250 1.2 Relevant identified uses of the substance or mixture and uses advised against For research use only. 1.3 Details of the supplier of the safety data sheet Company:Eton Bioscience Inc TollFree:1-800-758-1630 Tel:1-800-758-1630 Fax:1-800-507-2912 1.4 Emergency telephone number 1-800-758-1630 2. HAZARDS IDENTIFICATION 2.1 Classification of the substance or mixture Not a hazardous substance or mixture 2.2 GHS Label elements, including precautionary statements Not a hazardous substance or mixture 2.3 Other hazards None 3. COMPOSITION/INFORMATION ON INGREDIENTS 3.1 Substances Synonyms : Recombinant Serratiamarcescensextracellular endonuclease
CAS-No EC-No. Index-No Classification Concentration
Water
7732-18-5 231-791-2 - - >= 45 %
Glycerol
56-81-5 200-289-5 - - 50 %
Tris (hydroxymethyl) aminomethane free base
77-86-1 201-064-4 - Xi, R36/37/38 0.6 %
Enzyme
- - - - <= 0.025 %
Magnesium chloride hexahydrate
7791-18-6 232-094-6 - - 0.1 %
Sodium chloride
7647-14-5 231-598-3 - - 0.3 %
For the full text of the R-phrases mentioned in this Section, see Section 16. 4. FIRST AID MEASURES 4.1 Description of first aid measures Eye contact Check for and remove contact lenses and flush with copious amounts of water; assure adequate flushing by separating the eyelids with fingers; call a physician Skin Contact Flush with copious amounts of water; remove contaminated clothing and shoes; call a physician Inhalation Remove to fresh air. If not breathing give artificial respiration Ingestion If swallowed, never give anything by mouth to an unconscious person. Rinse mouth with water. 4.2 Most important symptoms and effects, both acute and delayed No information available 4.3 Indication of any immediate medical attention and special treatment needed. No information available 5. FIRE FIGHTING MEASURES 5.1 Extinguishing media Suitable extinguishing media Water spray, alcohol-resistant foam, dry chemical or carbon dioxide 5.2 Special hazards arising from the substance or mixture No information available 5.3 Advice for firefighters Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes. 6. ACCIDENTAL RELEASE MEASURES 6.1 Personal precautions,protective equipment and emergency procedures Use full personal protective equipment. Evacuate personnel to safe areas. Avoid breathing vapors,mist or gas. 6.2 Environmental precautions Prevent further leakage or spillage. Prevent product from entering drain. 6.3 Methods and material for containment and cleaning up Keep in suitable, closed containers for disposal 7. HANDLING AND STORAGE 7.1 Precautions for safe handling Avoid skin/eye contact. Use protective equipment as needed. Wash contaminated clothing before reuse. 7.2 Conditions for safe storage,including any incompatibilities Keep container tightly closed. Store at -80?C. 7.3 Specific end use(s) No data available. 8. EXPOSURE CONTROLS/PERSONAL INFORMATION 8.1 Control Parameters This product contains no hazardous materials with occupational exposure limits. 8.2 Exposure controls Engineering controls Provide shower and eye wash station Personal protective equipment
Eye Protection Wear safety goggles
Skin Protection Wear protective clothing
Hand Protection Wear protective gloves
Respiratory protection Wear NIOSH/MSHA approved respirators
9. PHYSICAL AND CHEMICAL PROPERTIES 9.1 Information on basic physical and chemical properties
Appearance Clear, colorless liquid
pH 8.0
Melting point No data available
Flash point No data available
Boiling point No data available
Ignition temperature No data available
Lower explosion limit No data available
Upper explosion limit No data available
Water solubility Soluble
9.2 Other safety information No data available. 10. STABILITY AND REACTIVITY 10.1Reactivity No data available 10.2Chemical stability Stable under recommended storage conditions. 10.3Possibility of hazardous reactions No data available. 10.4Conditions to avoid No data available 10.5Incompatible materials Strong oxidizing agents 10.6Hazardous decomposition products Hazardous decomposition products formed under fire conditions: carbon oxides 11. TOXICOLOGICAL INFORMATION 11.1Information on toxicological effects Acute toxicity No data available Irritation and corrosion No data available
Sensitisation Prolonged or repeated exposure may cause allergic reactions in certain sensitive individuals Chronic exposure IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. Signs and Symptoms o Exposure Prolonged or repeated exposure can cause:Nausea,Headache,Vomiting Potential Health Effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation
Skin May be harmful if absorbed through skin. May cause skin irritation
Eyes May cause eye irritation
Ingestion May be harmful if swallowed.
Target organs Kidney
12. ECOLOGICAL INFORMATION 12.1Toxicity Avoid release into environment 12.2Persistence and degradability No data available 12.3.Bioaccumulative potential No data available 12.4Mobility in soil No data available 12.5Results of PBT and vPvB assessment No data available 12.6Other adverse effects No data available 13. DISPOSAL INFORMATION 13.1Waste treatment methods Dispose in accordance with local, state, and federal regulations. 14. TRANSPORT INFORMATION DOT: Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport
IATA: Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport IMDG Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport 15. REGULATORY INFORMATION EU Risk and Safety phrases: R36/37/38: irritating to eyes/respiratory system/skin R20:Harmful by inhalation
R21:Harmful in contact with skin R22:Harmful if swallowed R52:Harmful to aquatic organisms R53:May cause long-term adverse effects in the aquatic environment 16. OTHER INFORMATION The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information. Eton Bioscience Inc. shall not be held liable for any damages or other consequences resulting from handling or from contact with the above product.

Demircioglu, F Esra et al. “Structures of TorsinA and Its Disease-Mutant Complexed with an Activator Reveal the Molecular Basis for Primary Dystonia.” Ed. Wesley I Sundquist. eLife 5 (2016): e17983. PMC. Web. 9 Aug. 2017. Knockenhauer, Kevin E., and Thomas U. Schwartz. “Structural Characterization of Bardet-Biedl Syndrome 9 Protein (BBS9).” The Journal of Biological Chemistry 290.32 (2015): 19569–19583. PMC. Web. 9 Aug. 2017.

San Diego Branch

Eton Bioscience, Inc.
10179 Huennekens Street,
Suite 201
San Diego, CA 92121
support@etonbio.com

North Carolina Branch

400 Park Offices Dr,
Suite 204
Research Triangle Park,
NC 27709
supportnc@etonbio.com

Boston Branch

56 Roland Street,
Suite 306 Floor 3R
Boston, MA 02129
supportma@etonbio.com

New Jersey Branch

1075 Morris Ave.,
Suite 503
Union, NJ 07083
supportnj@etonbio.com